Skip to main content
. 2020 Mar 4;19:1533033819896331. doi: 10.1177/1533033819896331

Figure 4.

Figure 4.

Genomic methylation status in MCF-7 human breast cancer cells and in exemestane-resistant MCF-7 (MCF-7/EXE) cells. (A) Viability assay of MCF-7 and MCF-7/EXE cells subjected to increasing concentrations of exemestane. (B) IC50 of MCF-7 and MCF-7/EXE were calculated using cell viability curve. Morphologies of (C) MCF-7 and (D) MCF-7/EXE (magnification: ×200). Comparisons between MCF-7 and MCF-7/EXE for (E) average genomic methylation ratio (MR) and (F) average genomic methylation density (MD). Comparisons between MCF-7 and MCF-7/EXE for (G) MR and (H) MD of chromosome 6 [32400000-32599999].